• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB
Click for more information
16.7% 0.7¢

PATRYS LIMITED

Market Cap $14.40M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAB
Ann: PAT-DX1 GMP specification testing update 		20/09/24 20 3.1K
20/09/24 Last post  Elu Comments Created with Sketch.  20  Views Created with Sketch.  3.1K 
PAB
Ann: PAT-DX1 GMP specification testing update 		20/09/24 56 17K
20/09/24 Last post  Travis Cloke Comments Created with Sketch.  56  Views Created with Sketch.  17K 
PAB
Ann: Further update on PAT-DX1 GMP manufacturing run
2
28/08/24 103 30K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
28/08/24 Last post  Travis Cloke Comments Created with Sketch.  103  Views Created with Sketch.  30K 
PAB
Ann: Appendix 4E and 2024 Annual Report 		24/08/24 4 1.6K
24/08/24 Last post  Thejerry01 Comments Created with Sketch.  4  Views Created with Sketch.  1.6K 
PAB
Ann: Appendix 4G and Corporate Governance Statement 		23/08/24 0 297
23/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 
PAB
Ann: Update on GMP manufacturing run of PAT-DX1 		27/07/24 10 6.8K
27/07/24 Last post  gassed Comments Created with Sketch.  10  Views Created with Sketch.  6.8K 
PAB
Ann: Appendix 4C - Quarterly - 30 June 2024 		26/07/24 18 4.9K
26/07/24 Last post  orion123 Comments Created with Sketch.  18  Views Created with Sketch.  4.9K 
PAB
M & A Activities 		22/07/24 13 5.4K
22/07/24 Last post  Outgoing123 Comments Created with Sketch.  13  Views Created with Sketch.  5.4K 

See All Discussions arrow Created with Sketch.

Timeline

PAT-DX1 GMP specification testing update
20 Sep 09:16
 
PAT-DX1 GMP specification testing update
29 Aug 09:15
 
Appendix 4G and Corporate Governance Statement
23 Aug 17:31
 
Appendix 4E and 2024 Annual Report
23 Aug 17:25
 
Further update on PAT-DX1 GMP manufacturing run
29 Jul 09:31
 
Appendix 4C - Quarterly - 30 June 2024
23 Jul 09:40
 
View More arrow Created with Sketch.

Featured News

NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.

(20min delay)
Last
0.7¢ 		Change
0.001(16.7%) 		Mkt cap ! $14.40M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $2.505K 375.8K

Buyers (Bids)

No. Vol. Price($)
9 4356781 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 2239285 4
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
0.001 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 430000
Last updated 10.34am 20/09/2024 ?
PAB (ASX) Chart

Top Stories

Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025

Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha

Featured News

NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.